Status:

RECRUITING

A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation

Lead Sponsor:

Caption Health, Inc.

Conditions:

Shortness of Breath

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to assess the efficacy of Caption LungAI.

Detailed Description

After being informed about the study, all patients giving written informed consent will undergo two 8-zone protocol lung ultrasound exams. One exam will be conducted by an expert lung ultrasound user ...

Eligibility Criteria

Inclusion

  • Patients over the age of 18
  • Patients presenting to the hospital or outpatient setting with shortness of breath and suspected B-lines.

Exclusion

  • Patients in extremis/in whom a research lung ultrasound would not normally be performed due to other priorities

Key Trial Info

Start Date :

July 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT05992324

Start Date

July 17 2023

End Date

March 1 2025

Last Update

November 26 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Yale New Haven Hospital

New Haven, Connecticut, United States, 06510

2

Northwestern University

Chicago, Illinois, United States, 60611

3

Rush University Medical Center

Chicago, Illinois, United States, 60612

4

The Moses H. Cone Memorial Hospital

Greensboro, North Carolina, United States, 27401